These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22959969)

  • 1. Plasma Kisspeptin-54 levels in gastric cancer patients.
    Ergen A; Canbay E; Bugra D; Zeybek U; Yamaner S; Bulut T
    Int J Surg; 2012; 10(9):551-4. PubMed ID: 22959969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kisspeptin-54 levels are increased in patients with colorectal cancer.
    Canbay E; Ergen A; Bugra D; Yamaner S; Eraltan IY; Buyukuncu Y; Bulut T
    World J Surg; 2012 Sep; 36(9):2218-24. PubMed ID: 22552499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
    Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma adiponectin and gastric cancer.
    Ishikawa M; Kitayama J; Kazama S; Hiramatsu T; Hatano K; Nagawa H
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):466-72. PubMed ID: 15701829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
    Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I
    Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Kisspeptin Levels in Newborn Infants with Breast Enlargement.
    Kaya A; Orbak Z; Polat H; Çayır A; Erdil A; Döneray H
    J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):192-6. PubMed ID: 26831552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer.
    Wang TB; Wang J; Wei XQ; Wei B; Dong WG
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):180-6. PubMed ID: 22524577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
    Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
    Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of plasma cell-free DNA in patients with gastric cancer.
    Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
    Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor.
    Lee JH; Ryu KW; Kim S; Bae JM
    Hepatogastroenterology; 2004; 51(60):1860-3. PubMed ID: 15532844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results regarding vascular endothelial growth factor (VEGF-A) levels in the serum of gastric cancer patients].
    Hălmaciu I; Gurzu S; Dobreanu M; Suciu BA; Brînzaniuc K
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):446-51. PubMed ID: 23077935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
    Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
    Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
    Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
    Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
    Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
    Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is SCUBE 1 a new biomarker for gastric cancer?
    Mentese A; Fidan E; Sumer AU; Karahan SC; Sonmez M; Altay DU; Kavgaci H; Alver A
    Cancer Biomark; 2012; 11(5):191-5. PubMed ID: 23220851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
    Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of preoperative plasma levels of big endothelin-1 to prognosis of gastric carcinoma].
    Teng XJ; Liu R; Zhang ZX; He JF; Shen ZX
    Ai Zheng; 2008 Jan; 27(1):88-91. PubMed ID: 18184472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome.
    Cetković A; Miljic D; Ljubić A; Patterson M; Ghatei M; Stamenković J; Nikolic-Djurovic M; Pekic S; Doknic M; Glišić A; Bloom S; Popovic V
    Endocr Res; 2012; 37(2):78-88. PubMed ID: 22489921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.